← Eichor
Condition: Acute Hiv Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acute Hiv Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT03449706
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV
Phase 1/Phase 2 · 12 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06071767
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Phase N/A · 1 location(s) · SEARCH Research Foundation · NCT00796146
Post Analytic Treatment Interruption Study
Phase N/A · 1 location(s) · SEARCH Research Foundation · NCT02761200
The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis
NA · 29 location(s) · Chishala Chabala · NCT06593080
Characterization of Acute and Recent HIV-1 Infections in Zurich.
Phase N/A · 1 location(s) · University of Zurich · NCT00537966
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Phase 1 · 1 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT06484335
Antiviral Clinical Trial for Long Covid-19
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06511063
Antiretroviral Therapy for Acute and Chronic HIV Infection
Phase 3 · 1 location(s) · SEARCH Research Foundation · NCT00796263
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689
Netherlands Cohort Study on Acute HIV Infection
Phase N/A · 1 location(s) · Prof. Jan Prins · NCT05728996
Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Phase 1 · 1 location(s) · U.S. Army Medical Research and Development Command · NCT06205056
Hep Mec Cohort in Zambia
Phase N/A · 3 location(s) · University of Alabama at Birmingham · NCT07589985
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 36 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.